News
Serena Williams, GLP-1 and Zepbound
Digest more
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 ...
Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...
At a time when shedding pounds may be just a shot away, WeightWatchers is returning to its roots and its community to chart a ...
The only GLP-1 medication that is FDA-approved to treat sleep apnea is Zepbound; it likely does this by lowering your weight. "If you are not overweight, medications like semaglutide and ...
Everyone is allowed to have their own opinion. But it’s important for me to own my own narrative and tell my own story.” ...
The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.
24/7 Wall St. on MSN1d
Eli Lilly Ranks Among Top Large-Cap Performers as GLP-1 Drug Sales Exceed Billions
Eli Lilly is one of the top growing stocks at the moment. Learn the reasons why this might be a stock to consider.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback